Loading...

Larkspur Health Acquisition Corp.

LSPRNASDAQ
Financial Services
Shell Companies
$22.50
$12.83(132.68%)

Larkspur Health Acquisition Corp. (LSPR) Stock Overview

Explore Larkspur Health Acquisition Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.2/100

Key Financials

Market Cap204.3M
P/E Ratio-0.00
EPS (TTM)N/A
ROE-1.12%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$173.90

LSPR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Larkspur Health Acquisition Corp. (LSPR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $173.90.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 204.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for LSPRStats details for LSPR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for LSPRAnalyst Recommendations details for LSPR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Larkspur Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on business in the biotechnology sector in the United States. The company was incorporated in 2021 and is based in Bridgewater, New Jersey.

CEO

Daniel J. O'Connor

Headquarters

100 Somerset Corporate Boulevard, Bridgewater, NJ

Founded

1970

Frequently Asked Questions

;